Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report

Patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer can benefit significantly from EGFR tyrosine-kinase inhibitors (TKIs) treatment, but almost every patient will inevitably develop resistance. The transformation to small cell lung cancer (SCLC) has been described...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Biol Ther
Hauptverfasser: Xie, Zhanhong, Gu, Yingying, Lin, Xinqing, Ouyang, Ming, Qin, Yinyin, Zhang, Jiexia, Liu, Junjun, Mai, Suiyi, Zhou, Chengzhi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2019
Schlagworte:
Bedside-to-Bench Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6741564/
https://ncbi.nlm.nih.gov/pubmed/31161851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1617561
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge